Alpa Lab
Ticker > Company >

Alpa Lab share price

Alpa Laboratories Ltd.

NSE: ALPA BSE: 532878 SECTOR: Pharmaceuticals & Drugs  41.25 K   103   9

93.79
-0.49 (-0.52%)
BSE: 18 Sep 04:01 PM

Price Summary

Today's High

₹ 94.75

Today's Low

₹ 93.79

52 Week High

₹ 144.6

52 Week Low

₹ 85

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 197.34 Cr.

Enterprise Value

₹ 201.33 Cr.

No. of Shares

2.1 Cr.

P/E

7.49

P/B

1.02

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  92

CASH

₹ 1.26 Cr.

DEBT

₹ 5.25 Cr.

Promoter Holding

57.29 %

EPS (TTM)

₹  12.52

Sales Growth

16.98%

ROE

10.93 %

ROCE

13.38%

Profit Growth

32.9 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.98%
3 Year3.68%
5 Year6.87%

Profit Growth

1 Year32.9%
3 Year32.18%
5 Year41.58%

ROE%

1 Year10.93%
3 Year10.46%
5 Year8.31%

ROCE %

1 Year13.38%
3 Year13.41%
5 Year10.92%

Debt/Equity

0.0324

Price to Cash Flow

53.35

Interest Cover Ratio

54.1066

CFO/PAT (5 Yr. Avg.)

0.58839009739313

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 57.29 0.00
Mar 2025 57.29 0.00
Dec 2024 57.29 0.00
Sep 2024 57.29 0.00
Jun 2024 57.29 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 32.1829881836138% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 54.1066.
  • Company’s PEG ratio is 0.227625570183366.
  • Company has a healthy liquidity position with current ratio of 5.7574.
  • The company has a high promoter holding of 57.29%.

 Limitations

  • The company has shown a poor revenue growth of 3.68429137532529% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 21.44 24.94 26.15 39.11 19.11
Total Expenditure 20.9 21.67 25.41 39.47 18.69
Operating Profit 0.54 3.27 0.74 -0.36 0.43
Other Income 5.16 6.91 8.8 3.24 11.96
Interest 0.05 0.06 0.1 0.05 0.05
Depreciation 0.54 0.53 0.55 0.58 0.55
Exceptional Items 0.02 0 0 0 0
Profit Before Tax 5.13 9.59 8.89 2.25 11.78
Tax 0 1.96 0 4.2 0
Profit After Tax 5.13 7.63 8.89 -1.95 11.78
Adjusted EPS (Rs) 2.44 3.63 4.23 -0.93 5.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 85.97 97.55 112.27 92.96 108.74
Total Expenditure 82.52 89.85 101.58 84.88 100.59
Operating Profit 3.45 7.71 10.69 8.08 8.14
Other Income 2.97 4.41 10.79 9.41 14.87
Interest 0.2 0.1 0.24 0.22 0.39
Depreciation 1.14 1.23 1.66 1.33 1.95
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.08 10.79 19.58 15.93 20.67
Tax 1 3.53 5.45 3.31 3.9
Net Profit 4.08 7.26 14.13 12.62 16.78
Adjusted EPS (Rs.) 1.94 3.45 6.71 6 7.97

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 21.04 21.04 21.04 21.04 21.04
Total Reserves 89.19 96.48 110.6 124.07 140.93
Borrowings 0.19 0.01 2.12 0.78 0
Other N/C liabilities -0.93 0.22 2.57 2.28 2.4
Current liabilities 20.78 32.49 28.8 29.92 28.06
Total Liabilities 130.28 150.23 165.14 178.09 192.42
Assets
Net Block 6.42 7.21 9.32 7.04 11.47
Capital WIP 0.81 1.57 0 0 0
Intangible WIP 0 0 0 0 0
Investments 28.31 21.24 17.03 16.82 16.38
Loans & Advances 0.24 0.23 0.22 1.45 0.52
Other N/C Assets 0.2 0.11 1.76 3.23 2.52
Current Assets 94.29 119.87 136.81 149.55 161.52
Total Assets 130.28 150.23 165.14 178.09 192.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 5.08 10.79 19.58 15.72 20.76
Adjustment 3.7 0.71 -7.95 -1.47 -9.86
Changes in Assets & Liabilities 9.99 -10.11 -5.85 -0.46 -3.57
Tax Paid -1.1 -2.87 -3.57 -3.6 -3.63
Operating Cash Flow 17.66 -1.47 2.2 10.2 3.7
Investing Cash Flow -11.27 5.82 -15.61 1.17 -12.45
Financing Cash Flow -1.35 -0.03 5.41 -3.48 2.26
Net Cash Flow 5.03 4.32 -7.99 7.89 -6.49

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 57.29 57.29 57.29 57.29 57.29
bakulesh chandulal shah h... 0.10 0.10 0.10 0.10 0.10
bakulesh shah 4.88 4.88 4.88 4.88 4.88
paresh chawla 17.52 17.52 17.52 17.52 34.26
rima shah 3.68 3.68 3.68 3.68 3.68
rupal shah 2.66 2.66 2.66 2.66 2.66
shitul shah 4.40 4.40 4.40 4.40 10.15
soni chawla 1.55 1.55 1.55 1.55 1.55
asha chawla 2.93 2.93 2.93 2.93 -
mahendra singh chawla 13.82 13.82 13.82 13.82 -
pravin shah 5.75 5.75 5.75 5.75 -
PARTICULARS Mar 2018% Jun 2018% Sep 2018% Dec 2018% Mar 2019%
investors 45.39 45.39 45.39 45.39 43.34
jasmin kishor ajmera 1.06 1.06 1.06 1.06 1.06
shanti rani chawla 1.73 1.73 1.73 1.73 -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Alpa Lab Stock Price Analysis and Quick Research Report. Is Alpa Lab an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Alpa Lab. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Alpa Lab has a PE ratio of 7.53199881825949 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Alpa Lab has ROA of 9.0565% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Alpa Lab has a Current ratio of 5.7574.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Alpa Lab has a ROE of 10.927%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Alpa Lab has a Debt to Equity ratio of 0.0324 which means that the company has low proportion of debt in its capital.

  • Sales growth: Alpa Lab has reported revenue growth of 16.98% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Alpa Lab for the current financial year is 7.49013693339095%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Alpa Lab is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Alpa Lab is Rs 12.5239. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Alpa Lab in Ticker for free. Also, one can get the intrinsic value of Alpa Lab by using Valuation Calculators, which are available with a Finology ONE subscription. 

Alpa Lab FAQs

Q1. What is Alpa Lab share price today?
Ans: The current share price of Alpa Lab is Rs 94.33.

Q2. What is the market capitalisation of Alpa Lab?
Ans: Alpa Lab has a market capitalisation of Rs 198.4759798 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Alpa Lab?
Ans: The PE ratio of Alpa Lab is 7.53199881825949 and the P/B ratio of Alpa Lab is 1.02529934001722, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Alpa Lab share?
Ans: The 52-week high share price of Alpa Lab is Rs 144.5, and the 52-week low share price of Alpa Lab is Rs 90.36.

Q5. Does Alpa Lab pay dividends?
Ans: Currently, Alpa Lab does not pay dividends. Dividend yield of Alpa Lab is around 0%.

Q6. What are the face value and book value of Alpa Lab shares?
Ans: The face value of Alpa Lab shares is Rs 10, while the book value per share of Alpa Lab is around Rs 92.0024. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Alpa Lab?
Ans: Alpa Lab has a total debt of Rs 5.2465 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Alpa Lab?
Ans: The ROE of Alpa Lab is 10.927% and ROCE of Alpa Lab is 13.3769%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Alpa Lab a good buy for the long term?
Ans: The Alpa Lab long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Alpa Lab undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Alpa Lab appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Alpa Lab’s financials?
Ans: You can review Alpa Lab’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Alpa Lab
X